Literature DB >> 28547098

Obstetrical and perinatal morbidity and mortality among in-vitro fertilization pregnancies: a population-based study.

Hussein Sabban1, Andrew Zakhari1, Valerie Patenaude2, Togas Tulandi1, Haim A Abenhaim3,4.   

Abstract

PURPOSE: To compare patient characteristics and obstetrical/neonatal outcomes of in-vitro fertilization (IVF) and spontaneously conceived pregnancies.
METHODS: Using the Nationwide Inpatient Sample, we conducted a retrospective cohort study from 2008 to 2011 comparing IVF conceptions to spontaneous ones. Patient characteristics were descriptively compared, and after adjusting for baseline characteristics with logistic regression, obstetrical/neonatal outcomes were also compared.
RESULTS: Among 3,315,764 pregnancies, 5773 (0.17%) were a result of IVF. These patients were more often older, wealthier, Caucasian, non-smokers, and more likely to carry a higher order pregnancy. IVF was strongly associated with pre-eclampsia (OR 1.48, 95% CI 1.32-1.62), gestational diabetes (OR 1.27, 95% CI 1.17-1.38), antepartum hemorrhage (OR 2.04, 95% CI 1.79-2.32), placenta previa (OR 3.14, 95% CI 2.71-3.64), pre-term premature rupture of membranes (OR 1.49, 95% CI 1.30-1.70), chorioamnionitis (OR 1.52, 1.29-1.79), and cesarean section (OR 1.60, 95% CI 1.51-1.70). There was a significantly increased risk of post-partum hemorrhage (OR 2.95, 95% CI 2.29-3.80) and hysterectomy (OR 1.73, 95% CI 1.12-2.69), as well as disseminated intravascular coagulopathy (OR 2.23, 95% CI 1.24-3.99), transfusion (OR 1.78, 95% CI 1.53-2.07), prolonged hospitalization (OR 1.96, 95% CI 1.80-2.14), intrauterine growth restriction (OR 1.81, 95% CI 1.63-2.02), and pre-term birth (OR 1.31, 95% CI 1.22-1.41).
CONCLUSION: IVF is still primarily used by only a subset of the population, and is associated with increased obstetrical and perinatal morbidity and mortality. These patients may benefit from more vigilant antenatal surveillance and delivery in a tertiary care center.

Entities:  

Keywords:  Assisted reproductive technology; In-vitro fertilization; Morbidity; Pregnancy

Mesh:

Year:  2017        PMID: 28547098     DOI: 10.1007/s00404-017-4379-8

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  11 in total

1.  Case-based discussion on the implications of exogenous estrogens in hemostasis and thrombosis: the hematologist's view.

Authors:  Margaret V Ragni
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2019-12-06

2.  Combined advanced parental age has an additive negative effect on live birth rates-data from 4057 first IVF/ICSI cycles.

Authors:  Nicole O McPherson; Deirdre Zander-Fox; Andrew D Vincent; Michelle Lane
Journal:  J Assist Reprod Genet       Date:  2017-10-04       Impact factor: 3.412

3.  Does contemporary ART lead to pre-eclampsia? A cohort study and meta-analysis.

Authors:  Shlomit Kenigsberg; Yaakov Bentov
Journal:  J Assist Reprod Genet       Date:  2021-01-19       Impact factor: 3.412

4.  Postpartum follow up of gestational diabetes in a Tertiary Care Center.

Authors:  C A Cabizuca; P S Rocha; J V Marques; T F L R Costa; A S N Santos; A L Schröder; C A G Mello; H D Sousa; E S G Silva; F O Braga; R C Abi-Abib; M B Gomes
Journal:  Diabetol Metab Syndr       Date:  2018-01-03       Impact factor: 3.320

5.  Use of Ballistocardiography to Monitor Cardiovascular Hemodynamics in Preeclampsia.

Authors:  Odayme Quesada; Md Mobashir Hasan Shandhi; Shire Beach; Sean Dowling; Damini Tandon; James Heller; Mozziyar Etemadi; Shuvo Roy; Juan M Gonzalez Velez; Omer T Inan; Liviu Klein
Journal:  Womens Health Rep (New Rochelle)       Date:  2021-04-20

Review 6.  Placenta Accreta Spectrum Disorder Complicated with Endometriosis: Systematic Review and Meta-Analysis.

Authors:  Shinya Matsuzaki; Yutaka Ueda; Yoshikazu Nagase; Satoko Matsuzaki; Mamoru Kakuda; Sahori Kakuda; Hitomi Sakaguchi; Tsuyoshi Hisa; Shoji Kamiura
Journal:  Biomedicines       Date:  2022-02-06

7.  In-Hospital Complications in Pregnancies Conceived by Assisted Reproductive Technology.

Authors:  Pensée Wu; Garima V Sharma; Laxmi S Mehta; Carolyn A Chew-Graham; Gina P Lundberg; Kara A Nerenberg; Michelle M Graham; Lucy C Chappell; Umesh T Kadam; Kelvin P Jordan; Mamas A Mamas
Journal:  J Am Heart Assoc       Date:  2022-02-22       Impact factor: 6.106

8.  Is vaginal progesterone treatment associated with the development of gestational diabetes? A retrospective case-control study.

Authors:  Klara Rosta; Johannes Ott; Fanni Kelemen; Wilhelm Temsch; Tobias Lahner; Theresa Reischer; Hanns Helmer; Aniko Somogyi
Journal:  Arch Gynecol Obstet       Date:  2018-09-17       Impact factor: 2.344

Review 9.  Acute Kidney Injury in Pregnancy: The Need for Higher Awareness. A Pragmatic Review Focused on What Could Be Improved in the Prevention and Care of Pregnancy-Related AKI, in the Year Dedicated to Women and Kidney Diseases.

Authors:  Giorgina Barbara Piccoli; Elena Zakharova; Rossella Attini; Margarita Ibarra Hernandez; Bianca Covella; Mona Alrukhaimi; Zhi-Hong Liu; Gloria Ashuntantang; Alejandra Orozco Guillen; Gianfranca Cabiddu; Philip Kam Tao Li; Gulliermo Garcia-Garcia; Adeera Levin
Journal:  J Clin Med       Date:  2018-10-01       Impact factor: 4.241

Review 10.  The Changing Landscape of Acute Kidney Injury in Pregnancy from an Obstetrics Perspective.

Authors:  Angela Vinturache; Joyce Popoola; Ingrid Watt-Coote
Journal:  J Clin Med       Date:  2019-09-06       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.